ANI Pharmaceuticals Inc (ANIP)

Current ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Total current assets	US$ in thousands	519,816	497,220	459,311	364,753	344,261	309,377	322,399	301,399	321,775	191,384	191,799	182,798	170,321	165,819	156,544	158,662	187,695	182,386	168,912	151,832
Total current liabilities	US$ in thousands	145,477	134,352	122,865	125,825	99,439	81,627	96,312	79,532	87,537	84,872	89,454	82,768	78,565	75,900	79,088	79,356	61,676	170,707	166,794	165,068
Current ratio		3.57	3.70	3.74	2.90	3.46	3.79	3.35	3.79	3.68	2.25	2.14	2.21	2.17	2.18	1.98	2.00	3.04	1.07	1.01	0.92

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $519,816K ÷ $145,477K
= 3.57

ANI Pharmaceuticals Inc's current ratio has exhibited some fluctuations over the last eight quarters. The current ratio, which measures the company's ability to cover its short-term liabilities with its short-term assets, stood at 3.57 in Q4 2023, indicating that the company had $3.57 in current assets for every $1 in current liabilities.

The current ratio peaked at 3.79 in Q3 2022 and Q1 2022, reflecting a slightly stronger liquidity position during those quarters. However, the ratio dropped to 2.90 in Q1 2023, suggesting a temporary decline in the company's ability to meet its short-term obligations with its current assets during that period.

Overall, ANI Pharmaceuticals Inc has generally maintained a healthy current ratio above 3.0 in most quarters, indicating a strong liquidity position and the ability to cover its short-term obligations comfortably. Investors and creditors typically view a current ratio above 2.0 as a positive sign of financial stability.